| Cost-effectiveness analysis of 1st through 3rd line sequential targeted therapy in HER2-positive metastatic breast cancer in the United States V Diaby, G Adunlin, AA Ali, SB Zeichner, G de Lima Lopes, CG Kohn, ... Breast cancer research and treatment 160, 187-196, 2016 | 46 | 2016 |
| Geographically-weighted regression analysis of percentage of late-stage prostate cancer diagnosis in Florida P Goovaerts, H Xiao, G Adunlin, A Ali, F Tan, CK Gwede, Y Huang Applied Geography 62, 191-200, 2015 | 37 | 2015 |
| Economic evaluation of sequencing strategies in HER2-positive metastatic breast cancer in Mexico: a contrast between public and private payer perspectives V Diaby, AA Ali, KJ Williams, K Ezendu, E Soto-Perez-de-Celis, ... Breast cancer research and treatment 166, 951-963, 2017 | 19 | 2017 |
| Value assessment frameworks in the United States: a call for patient engagement V Diaby, AA Ali, AJ Montero PharmacoEconomics-Open 3, 1-3, 2019 | 18 | 2019 |
| Impact of age, race and socio-economic status on temporal trends in late-stage prostate cancer diagnosis in Florida P Goovaerts, H Xiao, CK Gwede, F Tan, Y Huang, G Adunlin, A Ali Spatial statistics 14, 321-337, 2015 | 16 | 2015 |
| Using quality-adjusted progression-free survival as an outcome measure to assess the benefits of cancer drugs in randomized-controlled trials: case of the BOLERO-2 trial V Diaby, G Adunlin, AA Ali, R Tawk Breast cancer research and treatment 146, 669-673, 2014 | 16 | 2014 |
| Parameterization of a disease progression simulation model for sequentially treated metastatic human epidermal growth factor receptor 2 positive breast cancer patients V Diaby, AA Ali, G Adunlin, CG Kohn, AJ Montero Current medical research and opinion 32 (6), 991-996, 2016 | 15 | 2016 |
| Factors associated with time-to-treatment of prostate cancer in Florida H Xiao, F Tan, P Goovaerts, G Adunlin, AA Ali, Y Huang, CK Gwede Journal of health care for the poor and underserved 24 (4 0), 132, 2013 | 15 | 2013 |
| A cost-effectiveness analysis of trastuzumab-containing treatment sequences for HER-2 positive metastatic breast cancer patients in Taiwan V Diaby, H Alqhtani, S van Boemmel-Wegmann, CY Wang, AA Ali, ... The Breast 49, 141-148, 2020 | 13 | 2020 |
| Construction of a comorbidity index for prostate cancer patients linking state cancer registry with inpatient and outpatient data H Xiao, F Tan, P Goovaerts, AA Ali, G Adunlin, Y Huang, CK Gwede Journal of registry management 40 (4), 159, 2013 | 13 | 2013 |
| Engaging the community on colorectal cancer screening education: focus group discussions among African Americans JS Luque, M Vargas, K Wallace, OO Matthew, R Tawk, AA Ali, GE Kiros, ... Journal of Cancer Education 37 (2), 251-262, 2022 | 12 | 2022 |
| A cost-effectiveness analysis of rooming-in and breastfeeding in neonatal opioid withdrawal CM Avram, L Yieh, D Dukhovny, AB Caughey American journal of perinatology 37 (01), 001-007, 2020 | 12 | 2020 |
| Impact of comorbidities on prostate cancer stage at diagnosis in Florida H Xiao, F Tan, P Goovaerts, G Adunlin, AA Ali, CK Gwede, Y Huang American journal of men's health 10 (4), 285-295, 2016 | 11 | 2016 |
| Multilevel factors associated with overall mortality for men diagnosed with prostate cancer in Florida H Xiao, F Tan, P Goovaerts, A Ali, G Adunlin, CK Gwede, Y Huang American journal of men's health 8 (4), 316-326, 2014 | 10 | 2014 |
| Health insurance and breast-conserving surgery with radiation treatment AA Ali, H Xiao, GE Kiros Am J Manag Care 20 (6), 502-516, 2014 | 10 | 2014 |
| Assessing the level of patient-specific treatment recommendations in clinical practice guidelines for hemodialysis vascular access in the United States GL Queeley, ES Campbell, AA Ali American Health & Drug Benefits 11 (5), 223, 2018 | 9 | 2018 |
| Comparison of health utility weights among elderly patients receiving breast-conserving surgery plus hormonal therapy with or without radiotherapy AA Ali, H Xiao, R Tawk, E Campbell, A Semykina, AJ Montero, V Diaby Current medical research and opinion 33 (2), 391-400, 2017 | 9 | 2017 |
| Statins utilization trends and expenditures in the US before and after the implementation of the 2013 ACC/AHA guidelines A Matyori, CP Brown, A Ali, F Sherbeny Saudi Pharmaceutical Journal 31 (6), 795-800, 2023 | 8 | 2023 |
| Cost-effectiveness of treatments for HER2-positive metastatic breast cancer and associated metastases: an overview of systematic reviews V Diaby, RD Almutairi, A Babcock, RK Moussa, A Ali Expert review of pharmacoeconomics & outcomes research 21 (3), 353-364, 2021 | 8 | 2021 |
| Using time series analysis to forecast the health-related quality of life of post-menopausal women with non-metastatic ER+ breast cancer: a tutorial and case study H Xiao, X Jiang, C Chen, W Wang, CY Wang, AA Ali, A Berthe, ... Research in Social and Administrative Pharmacy 16 (8), 1095-1099, 2020 | 8 | 2020 |
Vakaramoko DiabyAssistant ProfessorEmail verificata su ufl.edu
